RxDoctor Payments Data

Alisha Nichols

Nurse Practitioner · Hot Springs, ARNPI 1275007072

Payments from drug & device makers

$2,461in general payments, 2019–2025

Across 149 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$572
  • Novo Nordisk$390
  • Pfizer$359
  • Boehringer Ingelheim$184
  • E.r. Squibb & Sons, L.L.C.$153
  • Irhythm Technologies, Inc.$135
  • plus $669 from 15 others

What the payments were for

  • Food & beverage$2,461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,461 in reported general payments places this provider in the 80th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$113,276
Medicare patients
638
Services billed
1,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban276$227,500
EntrestoSacubitril/Valsartan72$63,488
JardianceEmpagliflozin71$58,312
Repatha SureclickEvolocumab58$36,913
BrilintaTicagrelor49$35,326
XareltoRivaroxaban46$33,559
OzempicSemaglutide35$32,998
CorlanorIvabradine Hcl20$11,957
Repatha SyringeEvolocumab17$10,337
Metoprolol Succinate293$4,066
Potassium Chloride264$3,613
Bumetanide93$2,611
Ranolazine ErRanolazine12$2,286
Atorvastatin Calcium187$2,007
Enoxaparin Sodium18$1,730

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$359$227,500276 claims
NovartisEntresto$572$63,48872 claims
Boehringer IngelheimJardiance$184$58,31271 claims
AstraZenecaBrilinta$34$35,32649 claims
Johnson & JohnsonXarelto$80$33,55946 claims
Novo NordiskOzempic$390$32,99835 claims
AmgenCorlanor$107$11,95720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Hot Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →